SHANIKA TAYLOR-FIELDS: Open Payments
NPI 1780941088 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 11 payments from 7 companies in 2025. Trend: 2023 $122 · 2024 $127 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $62 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Braeburn Inc. | 2 | $41 |
| Lundbeck LLC | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: ARISTADA, BRIXADI, REXULTI, UZEDY, ABILIFY MAINTENA, CAPLYTA, ABILIFY ASIMTUFII, INVEGA SUSTENNA.
Industry payments across MO — which companies pay providers there.
